Trofe-Clark J - Search Results

1

Systematic Review of Calcineurin Inhibitor Monitoring and Dosing Strategies in Renal Transplantation: Notice of a New Report Funded by the Agency for Healthcare Research and Quality.

Tuteja S, Uhl S, Leas BF, Sawinski D, Trofe-Clark J, Kaczmarek JL, Umscheid CA. Tuteja S, et al. Clin Chem. 2016 Jun;62(6):900-1. doi: 10.1373/clinchem.2016.256479. Clin Chem. 2016. PMID: 27235470 Review. No abstract available.

2

BK virus genotype variance and discordant BK viremia PCR assay results.

Trofe-Clark J, Sparkes T, Gentile C, Van Deerlin V, Sawinski D, Bloom RD. Trofe-Clark J, et al. Am J Transplant. 2013 Apr;13(4):1112-1113. doi: 10.1111/ajt.12169. Epub 2013 Feb 22. Am J Transplant. 2013. PMID: 23432963 Free article. No abstract available.

3

Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies.

Sawinski D, Forde KA, Trofe-Clark J, Patel P, Olivera B, Goral S, Bloom RD. Sawinski D, et al. J Am Soc Nephrol. 2015 Apr;26(4):966-75. doi: 10.1681/ASN.2014010119. Epub 2014 Sep 25. J Am Soc Nephrol. 2015. PMID: 25255921 Free PMC article.

4

Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis.

Stevens DR, Sawinski D, Blumberg E, Galanakis N, Bloom RD, Trofe-Clark J. Stevens DR, et al. Transpl Infect Dis. 2015 Apr;17(2):163-73. doi: 10.1111/tid.12349. Epub 2015 Feb 6. Transpl Infect Dis. 2015. PMID: 25661673

5

Response to: lower-dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff.

Stevens DR, Sawinski D, Blumberg E, Bloom RD, Trofe-Clark J. Stevens DR, et al. Transpl Infect Dis. 2015 Aug;17(4):625-6. doi: 10.1111/tid.12396. Epub 2015 Jun 26. Transpl Infect Dis. 2015. PMID: 25919221 No abstract available.

6

Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents.

Sawinski D, Kaur N, Ajeti A, Trofe-Clark J, Lim M, Bleicher M, Goral S, Forde KA, Bloom RD. Sawinski D, et al. Am J Transplant. 2016 May;16(5):1588-95. doi: 10.1111/ajt.13620. Epub 2016 Feb 5. Am J Transplant. 2016. PMID: 26604182 Free article.

7

Calcineurin Inhibitor Minimization, Conversion, Withdrawal, and Avoidance Strategies in Renal Transplantation: A Systematic Review and Meta-Analysis.

Sawinski D, Trofe-Clark J, Leas B, Uhl S, Tuteja S, Kaczmarek JL, French B, Umscheid CA. Sawinski D, et al. Am J Transplant. 2016 Jul;16(7):2117-38. doi: 10.1111/ajt.13710. Epub 2016 Mar 15. Am J Transplant. 2016. PMID: 26990455 Free article. Review.

8

Calcineurin Inhibitors for Renal Transplant [Internet].

Leas BF, Uhl S, Sawinski DL, Trofe-Clark J, Tuteja S, Kaczmarek JL, Umscheid CA. Leas BF, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar. Report No.: 15(16)-EHC039-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar. Report No.: 15(16)-EHC039-EF. PMID: 27123504 Free Books & Documents. Review.

9

BK and Other Polyomaviruses in Kidney Transplantation.

Trofe-Clark J, Sawinski D. Trofe-Clark J, et al. Semin Nephrol. 2016 Sep;36(5):372-385. doi: 10.1016/j.semnephrol.2016.05.014. Semin Nephrol. 2016. PMID: 27772622 Review.

10

Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.

Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD, Reese PP. Koyawala N, et al. J Am Soc Nephrol. 2017 Jul;28(7):2188-2200. doi: 10.1681/ASN.2016070768. Epub 2017 Mar 20. J Am Soc Nephrol. 2017. PMID: 28320767 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page